Form 8-K - Current report:
SEC Accession No. 0001104659-25-060637
Filing Date
2025-06-18
Accepted
2025-06-18 16:12:21
Documents
12
Period of Report
2025-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518262d1_8k.htm   iXBRL 8-K 41014
  Complete submission text file 0001104659-25-060637.txt   206106

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20250613.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20250613_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20250613_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2518262d1_8k_htm.xml XML 3596
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 251057040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)